Literature DB >> 4855503

Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.

J Chiu, K N Drummond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4855503     DOI： 10.1016/s0022-3476(74)80757-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

1.  Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.

Authors:  B Oemar; J Brodehl
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

Review 2.  Problems with immunosuppressive agents in renal disease.

Authors:  J S Cameron
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

3.  Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.

Authors:  N Ueda; K Kuno; S Ito
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

4.  Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome.

Authors:  D P Jones; F B Stapleton; S Roy; R J Wyatt
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

5.  Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome.

Authors:  R Elhence; S Gulati; V Kher; A Gupta; R K Sharma
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

6.  Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.

Authors:  J S Cameron; C Chantler; C S Ogg; R H White
Journal:  Br Med J       Date:  1974-10-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.